IDEAYA completes darovasertib NDA, halts Phase 3 OptimUM-010 for enrollment issuesNov 3Quarterly updateAlector, Inc.Allogene Therapeutics
Novo Nordisk: BARI-STEP semaglutide trial results posted; two new Phase 1 studies registeredOct 28Weekly roundup, 7 itemsconcizumabdenecimig
Novo Nordisk registers Phase 3 trial for denecimig in acquired haemophilia A, plus new Phase 1 studySep 25Weekly roundup, 3 itemsdenecimigNNC0642-1895Updated